The global bio-implants market was valued at around US$ 117.3 Billion at the end of 2021. The market is projected to register a 10.0% CAGR and top a valuation of US$ 126.7 Billion by 2032.
Increasing dental implants, rapidly improving healthcare infrastructure, and increasing prevalence of chronic health disorders are expected to uplift the bio-implants market growth.
Bio-Implants are prosthetic devices used to replace, enhance or support a biological structure. They are composed of several biosynthetic components such as tissue-engineered products and collagen such as synthetic skin. The development of technology in the healthcare sector has led to a large increase in the market for bio-implants throughout the years. Although the healthcare sector has had significant technical advancements over the years, the advent of serious medical conditions has complicated the bio-implants market.
| Attributes | Details |
|---|---|
| Bio-Implants Market Value in 2021 | US$ 117.3 Billion |
| Bio-Implants Market Value in 2032 | US$ 126.5 Billion |
| Bio-Implants Market CAGR (2022 to 2032) | 10.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global market for bio-implants is anticipated to grow as a result of the rising prevalence of chronic health diseases particularly in the geriatric population and increasing disposable incomes. The healthcare infrastructure in developed and developing countries is expected to continue to rapidly improve, propelling the market for bio-implants to significant growth rates. Additionally, increasing awareness about the effectiveness of cosmetic implants and technological advancements. The market for bio-implants is rising due to an increase in dental problems worldwide. Due to the rising prevalence of cardiovascular and orthopedic problems, orthopedic artificial implants and cardiac pacemakers are in demand.
The established economy of North America is anticipated to drive demand for bio-implants, followed by Europe and other regions. The overall sales of bio-implant control in North America are anticipated to increase as the robust healthcare infrastructure, increased awareness of cosmetic implants, and major key players in the bio-implants market in this region. Furthermore, with technological advancements in healthcare, increased demand for nonsurgical bio-implants, and a rising geriatric population, Europe is the world's second-largest market for bio-implants.
Moreover, as a result of the large production of bio-implants in numerous therapeutic fields and the rising prevalence of chronic diseases, the Middle East and Africa(MEA) region has the potential to be a market for bio-implants.
Principal Consultant
Some of the market players operating in the bio-implants market are LifeNet Health, Smith & Nephew, Arthrex, Inc., Clinic Lemanic, Alpha Bio Tec, MiMedx Group, Medtronic, St Jude Medical (Abbott), Stryker Cooperation, DePuy Synthes, Biomet (Zimmer), Exactech, Inc., Cochlear Ltd, Straumann AG. and others.
| Report Attributes | Details |
|---|---|
| Growth Rate | CAGR of 10.0% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2012 to 2021 |
| Forecast Period | 2022 to 2032 |
| Qualitative Units | Revenue in USD Billion, Volume in Units, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segment Covered | Product, Material, Origin, End User, Region |
| Region Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Israel |
| Key Players | LifeNet Health; Smith & Nephew; Arthrex, Inc.; Clinic Lemanic; Alpha Bio Tec; MiMedx Group; Medtronic; St Jude Medical (Abbott); Stryker Cooperation; DePuy Synthes; Biomet (Zimmer); Exactech, Inc.; Cochlear Ltd; Straumann AG |
| Customization | Available Upon Request |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The global bio-implants market is anticipated to register a CAGR of 10.0% during the forecast period.
The top players in the global bio-implants control market are LifeNet Health, Smith & Nephew, Arthrex, Inc., Clinic Lemanic, Alpha Bio Tec, MiMedx Group, Medtronic, St Jude Medical (Abbott), Stryker Cooperation, DePuy Synthes, Biomet (Zimmer), Exactech, Inc., Cochlear Ltd, Straumann AG.
Explore Healthcare Insights
View Reports
Bio-Implants Market
